Related Experiment Video
Updated: Sep 28, 2026
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Novel cocrystal inclusion compound of bezafibrate with l-proline: preparation, characterization, and in vitro/in vivo
Kangjie Wen1, Hongguo Han1, Tingyu Jin1
1College of Pharmaceutical Sciences, Key Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education, Zhejiang University of Technology, Hangzhou, China.
Context:
Bezafibrate (BEZA) suffers from poor water solubility, which severely restricts its in vitro dissolution performance and further limits in vivo bioavailability.
Objective:
To improve the solubility and dissolution of BEZA and enhance its bioavailability.
Methods:
The cocrystal of BEZA and L-proline (L-Pro) (BEZA-L-Pro cocrystal) was prepared using liquid-assisted ball milling method. Additionally, the BEZA-L-Pro/hydroxypropyl-β-cyclodextrin (HP-β-CD) inclusion compound was prepared through neat ball milling. The preparation conditions were optimized. The formation of the cocrystal and inclusion compound was confirmed by powder X-ray diffraction, differential scanning calorimetry, Fourier-transform infrared spectroscopy and scanning electron microscopy. The stoichiometry of the inclusion compound was determined by phase solubility tests.
Results:
The optimal cocrystal preparation conditions were: BEZA to L-Pro molar ratio of 1: 1, ethanol as solvent, η of 0.8 μL/mg, milling speed of 150 rpm. The optimal inclusion compound preparation conditions were: BEZA-L-Pro to HP-β-CD molar ratio of 1: 1, milling speed of 200 rpm. The saturation solubility test showed that the saturation solubility of cocrystal and inclusion compound was 1.48 times and 3.91 times of BEZA, respectively. The dissolution test showed that the cumulative release rate of cocrystal and inclusion compound in acetate buffer solution (pH 4.5) within 120 min was 2.5 times and 4 times of BEZA, respectively. The in vivo study demonstrated that the bioavailability of cocrystal and inclusion compound was 1.4 times and 2 times of BEZA, respectively.
Conclusion:
The prepared BEZA-L-Pro cocrystal and BEZA-L-Pro/HP-β-CD inclusion compound can significantly improve the solubility and dissolution of BEZA, and enhance its bioavailability.
